FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2981151070> ?p ?o ?g. }

• W2981151070 abstract "The α7 nicotinic acetylcholine receptor (α7nAChR) is a ligand-gated ion channel implicated in cognition and neuropsychiatric disorders. A unique feature of the α7nAChR is the presence in different copy number variations (CNV) and orientation of CHRFAM7A, a human specific fusion gene, which harbors exons 5–10 of CHRNA7 and exons A-E of the FAM7 sequence. An association between CHRFAM7A dosage and Alzheimer's Disease (AD) has been reported (CNV GWAS); CHRFAM7A lower CNV and expression levels is associated with AD. In contrast, its upregulation and a correlation with the inverted orientation is observed in schizophrenia and bipolar disorder. While the α7nAChR has been a promising target for neuropsychiatric disorders, the effect observed in animal models failed to translate into human clinical trials. We hypothesized that CHRFAM7A, a human specific gene with properties that enable incorporation into the α7nAChR, may account for the translational gap; understanding its function may offer novel insights when exploring α7nAChR as a drug target. To study the functional consequences of the presence of the CHRFAM7A, three iPSC lines (0 copy, 1 copy direct, and 1 copy inverted) were developed and Medial Ganglionic Eminence progenitors and neurons were generated. The 0 copy line was rescued with CHRFAM7A transfection to control for genetic heterogeneity. As readouts for genotype-phenotype correlation, α7nAChR synaptic transmission and Aβ1-42 uptake were tested. Synaptic transmission in the presence of CHRFAM7A (1 copy direct line) demonstrated that PNU-modulated desensitization of α7nAChR currents increased as a function of CHRFAM7A dosage. While CHRFAM7A (direct orientation) mitigated the dose response of Aβ1–42 uptake suggesting a protective effect beyond physiological concentrations, its presence in the inverted orientation did not have this effect. Furthermore, in the presence of CHRFAM7A (direct orientation) Aβ1–42 uptake activated neuronal interleukin 1β and TNFα. Preliminary data on potential mechanisms are discussed and the involvement of autophagy and inflammasome signaling is elaborated. A current study revealed functional differences between structural variants of CHRFAM7A: the 1 copy direct line mitigated the dose response of Aβ1–42 uptake and modulated α7nAChR. Lead optimization may identify more potent molecules when the screen has a model harboring CHRFAM7A." @default.
• W2981151070 created "2019-10-25" @default.
• W2981151070 creator A5014613365 @default.
• W2981151070 creator A5018943967 @default.
• W2981151070 creator A5020771957 @default.
• W2981151070 creator A5036964780 @default.
• W2981151070 creator A5039529010 @default.
• W2981151070 creator A5064835126 @default.
• W2981151070 creator A5071043507 @default.
• W2981151070 creator A5086540524 @default.
• W2981151070 creator A5014035227 @default.
• W2981151070 date "2019-07-01" @default.
• W2981151070 modified "2023-10-17" @default.
• W2981151070 title "P3-203: FUNCTIONAL CHARACTERIZATION OF STRUCTURAL VARIANTS OF CHRFAM7A" @default.
• W2981151070 doi "https://doi.org/10.1016/j.jalz.2019.06.3233" @default.
• W2981151070 hasPublicationYear "2019" @default.
• W2981151070 type Work @default.
• W2981151070 sameAs 2981151070 @default.
• W2981151070 citedByCount "0" @default.
• W2981151070 crossrefType "journal-article" @default.
• W2981151070 hasAuthorship W2981151070A5014035227 @default.
• W2981151070 hasAuthorship W2981151070A5014613365 @default.
• W2981151070 hasAuthorship W2981151070A5018943967 @default.
• W2981151070 hasAuthorship W2981151070A5020771957 @default.
• W2981151070 hasAuthorship W2981151070A5036964780 @default.
• W2981151070 hasAuthorship W2981151070A5039529010 @default.
• W2981151070 hasAuthorship W2981151070A5064835126 @default.
• W2981151070 hasAuthorship W2981151070A5071043507 @default.
• W2981151070 hasAuthorship W2981151070A5086540524 @default.
• W2981151070 hasBestOaLocation W29811510701 @default.
• W2981151070 hasConcept C104317684 @default.
• W2981151070 hasConcept C120821319 @default.
• W2981151070 hasConcept C141231307 @default.
• W2981151070 hasConcept C169760540 @default.
• W2981151070 hasConcept C36823959 @default.
• W2981151070 hasConcept C54355233 @default.
• W2981151070 hasConcept C86803240 @default.
• W2981151070 hasConceptScore W2981151070C104317684 @default.
• W2981151070 hasConceptScore W2981151070C120821319 @default.
• W2981151070 hasConceptScore W2981151070C141231307 @default.
• W2981151070 hasConceptScore W2981151070C169760540 @default.
• W2981151070 hasConceptScore W2981151070C36823959 @default.
• W2981151070 hasConceptScore W2981151070C54355233 @default.
• W2981151070 hasConceptScore W2981151070C86803240 @default.
• W2981151070 hasIssue "7S_Part_19" @default.
• W2981151070 hasLocation W29811510701 @default.
• W2981151070 hasOpenAccess W2981151070 @default.
• W2981151070 hasPrimaryLocation W29811510701 @default.
• W2981151070 hasRelatedWork W2002128513 @default.
• W2981151070 hasRelatedWork W2025851750 @default.
• W2981151070 hasRelatedWork W2039352533 @default.
• W2981151070 hasRelatedWork W2073595570 @default.
• W2981151070 hasRelatedWork W2092554027 @default.
• W2981151070 hasRelatedWork W2168467210 @default.
• W2981151070 hasRelatedWork W2171277769 @default.
• W2981151070 hasRelatedWork W2738956114 @default.
• W2981151070 hasRelatedWork W4242521457 @default.
• W2981151070 hasRelatedWork W2092874662 @default.
• W2981151070 hasVolume "15" @default.
• W2981151070 isParatext "false" @default.
• W2981151070 isRetracted "false" @default.
• W2981151070 magId "2981151070" @default.
• W2981151070 workType "article" @default.